DK1065196T3 - Fremgangsmåde til selektiv adskillelse og oprensning af eicosanpentaensyre og docosahexaensyre eller estere deraf - Google Patents

Fremgangsmåde til selektiv adskillelse og oprensning af eicosanpentaensyre og docosahexaensyre eller estere deraf

Info

Publication number
DK1065196T3
DK1065196T3 DK00113020T DK00113020T DK1065196T3 DK 1065196 T3 DK1065196 T3 DK 1065196T3 DK 00113020 T DK00113020 T DK 00113020T DK 00113020 T DK00113020 T DK 00113020T DK 1065196 T3 DK1065196 T3 DK 1065196T3
Authority
DK
Denmark
Prior art keywords
acid
esters
eicosan
purification
selective separation
Prior art date
Application number
DK00113020T
Other languages
English (en)
Inventor
Satoshi Kiyohara
Shiro Nisshin Fujita
Original Assignee
Nisshin Pharma Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Nisshin Pharma Inc filed Critical Nisshin Pharma Inc
Application granted granted Critical
Publication of DK1065196T3 publication Critical patent/DK1065196T3/da

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C51/00Preparation of carboxylic acids or their salts, halides or anhydrides
    • C07C51/42Separation; Purification; Stabilisation; Use of additives
    • C07C51/47Separation; Purification; Stabilisation; Use of additives by solid-liquid treatment; by chemisorption
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C67/00Preparation of carboxylic acid esters
    • C07C67/48Separation; Purification; Stabilisation; Use of additives
    • C07C67/56Separation; Purification; Stabilisation; Use of additives by solid-liquid treatment; by chemisorption

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Fats And Perfumes (AREA)
DK00113020T 1999-06-28 2000-06-21 Fremgangsmåde til selektiv adskillelse og oprensning af eicosanpentaensyre og docosahexaensyre eller estere deraf DK1065196T3 (da)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP18140799 1999-06-28

Publications (1)

Publication Number Publication Date
DK1065196T3 true DK1065196T3 (da) 2003-09-22

Family

ID=16100230

Family Applications (1)

Application Number Title Priority Date Filing Date
DK00113020T DK1065196T3 (da) 1999-06-28 2000-06-21 Fremgangsmåde til selektiv adskillelse og oprensning af eicosanpentaensyre og docosahexaensyre eller estere deraf

Country Status (7)

Country Link
US (1) US6313330B1 (da)
EP (1) EP1065196B1 (da)
AT (1) ATE241584T1 (da)
CA (1) CA2311974A1 (da)
DE (1) DE60002952T2 (da)
DK (1) DK1065196T3 (da)
NO (1) NO321273B1 (da)

Families Citing this family (49)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE602004029090D1 (de) 2003-12-30 2010-10-21 Dsm Ip Assets Bv Entlüftungsverfahren
RU2444356C2 (ru) * 2005-07-08 2012-03-10 Мартек Байосайенсиз Корпорейшн Полиненасыщенные жирные кислоты для лечения деменции и состояний, связанных с преддеменцией
AU2008269989B2 (en) * 2007-06-29 2014-02-27 Dsm Ip Assets B.V. Production and purification of esters of polyunsaturated fatty acids
EP4137128A1 (en) 2008-09-02 2023-02-22 Amarin Pharmaceuticals Ireland Limited Pharmaceutical composition comprising eicosapentaenoic acid and a statin, and methods of using same
JP5503856B2 (ja) * 2008-09-10 2014-05-28 キユーピー株式会社 高度不飽和脂肪酸誘導体の取得方法
ES2574136T5 (es) 2009-04-17 2019-08-30 Natac Pharma S L Composiciones ricas en ácidos grasos omega 3 con un bajo contenido en ácido fitánico
MX350088B (es) 2009-04-29 2017-08-25 Amarin Pharma Inc Composicion farmaceutica estable y metodos de uso de la misma.
NZ720946A (en) 2009-04-29 2017-09-29 Amarin Pharmaceuticals Ie Ltd Pharmaceutical compositions comprising epa and a cardiovascular agent and methods of using the same
CN108096209A (zh) 2009-06-15 2018-06-01 阿马里纳制药公司 在相伴他汀类疗法的对象中降低甘油三酯、没有增加ldl-c水平的组合物和方法
US20110071176A1 (en) 2009-09-23 2011-03-24 Amarin Pharma, Inc. Pharmaceutical composition comprising omega-3 fatty acid and hydroxy-derivative of a statin and methods of using same
CA2873141C (en) 2009-12-30 2018-05-29 Adam Kelliher Simulated moving bed chromatographic separation process
NZ712068A (en) 2010-11-29 2017-03-31 Amarin Pharmaceuticals Ie Ltd Low eructation composition and methods for treating and/or preventing cardiovascular disease in a subject with fish allergy/hypersensitivity
US11712429B2 (en) 2010-11-29 2023-08-01 Amarin Pharmaceuticals Ireland Limited Low eructation composition and methods for treating and/or preventing cardiovascular disease in a subject with fish allergy/hypersensitivity
GB201111589D0 (en) 2011-07-06 2011-08-24 Equateq Ltd New modified process
GB201111591D0 (en) 2011-07-06 2011-08-24 Equateq Ltd Further new process
GB201111601D0 (en) 2011-07-06 2011-08-24 Equateq Ltd New process
GB201111595D0 (en) 2011-07-06 2011-08-24 Equateq Ltd Improved process
GB201111594D0 (en) 2011-07-06 2011-08-24 Equateq Ltd New improved process
US11291643B2 (en) 2011-11-07 2022-04-05 Amarin Pharmaceuticals Ireland Limited Methods of treating hypertriglyceridemia
US20130131170A1 (en) 2011-11-07 2013-05-23 Amarin Pharmaceuticals Ireland Limited Methods of treating hypertriglyceridemia
ES2891473T3 (es) 2012-01-06 2022-01-28 Amarin Pharmaceuticals Ie Ltd Composiciones y métodos para reducir los niveles de alta sensibilidad (hs-CRP) en un sujeto
CA3067012C (en) 2012-06-29 2021-10-05 Amarin Pharmaceuticals Ireland Limited Methods of reducing the risk of a cardiovascular event in a subject on statin therapy
WO2014074552A2 (en) 2012-11-06 2014-05-15 Amarin Pharmaceuticals Ireland Limited Compositions and methods for lowering triglycerides without raising ldl-c levels in a subject on concomitant statin therapy
US9814733B2 (en) 2012-12-31 2017-11-14 A,arin Pharmaceuticals Ireland Limited Compositions comprising EPA and obeticholic acid and methods of use thereof
US20140187633A1 (en) 2012-12-31 2014-07-03 Amarin Pharmaceuticals Ireland Limited Methods of treating or preventing nonalcoholic steatohepatitis and/or primary biliary cirrhosis
GB201300354D0 (en) 2013-01-09 2013-02-20 Basf Pharma Callanish Ltd Multi-step separation process
US9452151B2 (en) 2013-02-06 2016-09-27 Amarin Pharmaceuticals Ireland Limited Methods of reducing apolipoprotein C-III
US9624492B2 (en) 2013-02-13 2017-04-18 Amarin Pharmaceuticals Ireland Limited Compositions comprising eicosapentaenoic acid and mipomersen and methods of use thereof
US9662307B2 (en) 2013-02-19 2017-05-30 The Regents Of The University Of Colorado Compositions comprising eicosapentaenoic acid and a hydroxyl compound and methods of use thereof
US9283201B2 (en) 2013-03-14 2016-03-15 Amarin Pharmaceuticals Ireland Limited Compositions and methods for treating or preventing obesity in a subject in need thereof
US20140271841A1 (en) 2013-03-15 2014-09-18 Amarin Pharmaceuticals Ireland Limited Pharmaceutical composition comprising eicosapentaenoic acid and derivatives thereof and a statin
US8802880B1 (en) 2013-05-07 2014-08-12 Group Novasep Chromatographic process for the production of highly purified polyunsaturated fatty acids
US9428711B2 (en) 2013-05-07 2016-08-30 Groupe Novasep Chromatographic process for the production of highly purified polyunsaturated fatty acids
US10966968B2 (en) 2013-06-06 2021-04-06 Amarin Pharmaceuticals Ireland Limited Co-administration of rosiglitazone and eicosapentaenoic acid or a derivative thereof
US20150065572A1 (en) 2013-09-04 2015-03-05 Amarin Pharmaceuticals Ireland Limited Methods of treating or preventing prostate cancer
US9585859B2 (en) 2013-10-10 2017-03-07 Amarin Pharmaceuticals Ireland Limited Compositions and methods for lowering triglycerides without raising LDL-C levels in a subject on concomitant statin therapy
CN103962091B (zh) * 2013-11-28 2017-01-25 大连工业大学 一种银离子改性氨基硅胶分离epa和dha的方法
EP2883860B1 (fr) 2013-12-11 2016-08-24 Novasep Process Procédé chromatographique de production d'acides gras polyinsaturés
JP6303017B2 (ja) 2014-01-07 2018-03-28 ノヴァセプ プロセスNovasep Process 芳香族アミノ酸を精製する方法
US10561631B2 (en) 2014-06-11 2020-02-18 Amarin Pharmaceuticals Ireland Limited Methods of reducing RLP-C
US10172818B2 (en) 2014-06-16 2019-01-08 Amarin Pharmaceuticals Ireland Limited Methods of reducing or preventing oxidation of small dense LDL or membrane polyunsaturated fatty acids
US10406130B2 (en) 2016-03-15 2019-09-10 Amarin Pharmaceuticals Ireland Limited Methods of reducing or preventing oxidation of small dense LDL or membrane polyunsaturated fatty acids
WO2018213663A1 (en) 2017-05-19 2018-11-22 Amarin Pharmaceuticals Ireland Limited Compositions and methods for lowering triglycerides in a subject having reduced kidney function
US11058661B2 (en) 2018-03-02 2021-07-13 Amarin Pharmaceuticals Ireland Limited Compositions and methods for lowering triglycerides in a subject on concomitant statin therapy and having hsCRP levels of at least about 2 mg/L
MA51766A (fr) 2018-09-24 2020-12-16 Amarin Pharmaceuticals Ie Ltd Procédés de réduction du risque d'événements cardiovasculaires chez un sujet
US11767491B2 (en) 2019-03-26 2023-09-26 Nisshin Pharma Inc. Eicosapentaenoic acid alkyl ester-containing composition and method for producing same
CN109912403A (zh) * 2019-04-18 2019-06-21 南京市第一医院 一种Omega-3制备大电导钙激活钾通道开放剂的方法
BR112022009189A2 (pt) 2019-11-12 2022-07-26 Amarin Pharmaceuticals Ie Ltd Métodos para reduzir o risco de eventos cardiovasculares em um sujeito com fibrilação atrial e/ou palpitação atrial
US11986452B2 (en) 2021-04-21 2024-05-21 Amarin Pharmaceuticals Ireland Limited Methods of reducing the risk of heart failure

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0347509A1 (en) * 1988-06-21 1989-12-27 Century Laboratories Inc. A process of extraction and purification of polyunsaturated fatty acids from natural sources
JPH028298A (ja) * 1988-06-17 1990-01-11 Agency Of Ind Science & Technol イカ内臓からドコサヘキサエン酸及びエイコサペンタエン酸を選択的に分離精製する方法
JPH07242895A (ja) * 1993-03-16 1995-09-19 Ikeda Shiyotsuken Kk 高純度エイコサペンタエン酸又はその低級アルコールエステルの分離精製法
JPH09151390A (ja) * 1995-11-30 1997-06-10 Bizen Kasei Kk 高度不飽和脂肪酸及びその誘導体の精製方法
JPH10310551A (ja) * 1997-05-12 1998-11-24 Nippon Wax Polymer Kaihatsu Kenkyusho:Kk エイコサペンタエン酸又はそのエステルの精製方法

Also Published As

Publication number Publication date
EP1065196A1 (en) 2001-01-03
DE60002952T2 (de) 2004-03-11
EP1065196B1 (en) 2003-05-28
US6313330B1 (en) 2001-11-06
NO20003335D0 (no) 2000-06-26
DE60002952D1 (de) 2003-07-03
NO321273B1 (no) 2006-04-10
CA2311974A1 (en) 2000-12-28
ATE241584T1 (de) 2003-06-15
NO20003335L (no) 2000-12-29

Similar Documents

Publication Publication Date Title
NO20003335L (no) Fremgangsmåte for selektiv separering og rensing av eikosapentaen- og dokosaheksaensyrer eller deres estere
JP5951764B2 (ja) 魚油から高純度のepaを生成するためのsmb方法
ES2459951T3 (es) Proceso de separación cromatográfico de lecho móvil simulado para la purificación de ácidos grasos poliinsaturados
JP5990580B2 (ja) 新規なsmb方法
DK1106602T3 (da) Kromatografisk simulated moving bed-oprensning af aminosyrer
DK0658164T3 (da) Fremgangsmåde til chromatografisk oprensning og adskillelse af nukleinsyreblandinger
JP5946833B2 (ja) ω3脂肪酸を濃縮する方法
IS5133A (is) Hreinsun á fjölómettuðum fitusýruglýseríðum
ES2097047T3 (es) Procedimientos para el fraccionamiento cromatografico de acidos grasos y sus derivados.
JP2014518312A (ja) Smb方法
JP2003500082A (ja) 蒸留−酵素的エステル交換の組合せによるポリ不飽和脂肪酸エステルの濃縮及び精製
Lembke Production techniques for omega-3 concentrates
DE69230273D1 (de) Verfahren zur Reinigung von Serumalbumin
DE502006008403D1 (de) Verfahren zur abtrennung von säuren aus chemischen reaktionsgemischen mit hilfe unpolarer tertiärer amine
DK1644469T4 (da) Fremgangsmåde til fremstilling af oprensede fedtsyrer
BR9913720A (pt) Processo de purificação por cristalização ourecristalização de ácidos carboxìlicos
DK0780374T3 (da) Fremgangsmåde til reduktion af indholdet af vand og polære urenheder i imidoalkanpercarboxylsyre
DE68928249D1 (de) Verfahren zur Trennung von Methylester von alpha-L-aspartyl-L-phenylalaninen
JPS5786254A (en) Healthful food
ES2289898B1 (es) Metodo rapido y biocompatible de extraccion, saponificacion y concentracion de acidos grasos poliinsaturados (pufas) por diferencias de solubilidad a partir de biomasa.
JPS572237A (en) Separation of medical component of corbicula through extraction and composition comprising it
DK0706990T3 (da) Fremgangsmåde til separation af en (meth)acrylsyremonoester af en C4-C6-alkandiol fra en vandig opløsning indeholdende en (
PL363073A1 (pl) Sposób regenerowania kwasów z wodnego roztworu zawierającego metale przez ekstrakcję w układzie ciecz/ciecz
JPS5235799A (en) Recovery method for zeolite
RU2001114727A (ru) Способ выделения калиевой соли феноксиметилпенициллина